Latest week
17 Jul 2026
Close
66475.000000
Fair value
39676.298396
Next-week expectancy
Undecided 49.79%
Sharemaestro

AZN Chart Pack

AstraZeneca PLC

Exchange
BUE
Latest week
17 Jul 2026
Close
66475.000000
Fair value
39676.298396
Next-week expectancy
Undecided 49.79%
Generated
18 Jul 2026 11:32
Sector
Healthcare
Industry
Drug Manufacturers - General

Chart Summary

Over the latest 12 completed weeks ending 2026-07-17, AZN fell 5.74%, moving from 70,525.00 to 66,475.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -17.13 and has softened across the 12-week window. Market Dynamics is -0.26 on the latest week. Next-week expectancy is undecided at 49.79% based on similar historical setup states.

Key Points

Week Ending
17 Jul 2026
Latest Close
66,475.00
12-Week Change
-5.74%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 49.79%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-17.13
Market Dynamics
-0.26

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
17 Jul 2026
Latest Close
66,475.00
12-Week Change
-5.74%
Trend Signal
Inactive
Next-Week Expectancy
Undecided 49.79%
Signal Weeks
2 of 12
Vs Trend Line
Below
Vs Fair Value
Above
Relative Strength
-17.13
Market Dynamics
-0.26

Over the latest 12 completed weeks ending 2026-07-17, AZN fell 5.74%, moving from 70,525.00 to 66,475.00. The latest weekly close is below the Trend Line and above Fair Value. Trend Signal is inactive on the latest week and was active in 2 of the last 12 weeks. Relative Strength is -17.13 and has softened across the 12-week window. Market Dynamics is -0.26 on the latest week. Next-week expectancy is undecided at 49.79% based on similar historical setup states.

Industry Peers

Argentina equities in Drug Manufacturers - General

Stock Exchange Week Open High Low Close Change
BMY Bristol-Myers Squibb Company BUE 17 Jul 2026 30120.00 32560.00 29420.00 31940.00 6.04%
ABBV AbbVie Inc. BUE 17 Jul 2026 38460.01 40940.00 37744.84 40320.00 4.84%
GILD Gilead Sciences, Inc. BUE 17 Jul 2026 50900.00 55075.00 50550.00 53025.00 4.17%
PFE Pfizer Inc. BUE 17 Jul 2026 9500.00 10060.00 9385.00 9885.00 4.05%
BIIB Biogen Inc. BUE 17 Jul 2026 24000.00 26040.00 22380.00 24890.00 3.71%
MRK Merck & Co., Inc. BUE 17 Jul 2026 38800.00 41460.00 37540.00 40160.00 3.51%
AMGN Amgen Inc. BUE 17 Jul 2026 18880.00 19780.00 18410.00 19200.00 1.69%
NVS Novartis AG BUE 17 Jul 2026 60175.00 60875.00 58100.00 60675.00 0.83%
LLY Eli Lilly and Company BUE 17 Jul 2026 33100.00 33560.00 31480.00 33160.00 0.18%
DJNJ3 Johnson & Johnson BUE 17 Jul 2026 1640.00 1640.00 1640.00 1640.00 0.00%
GSK GSK plc BUE 17 Jul 2026 20550.00 20690.00 19940.00 20470.00 -0.39%
JNJ Johnson & Johnson BUE 17 Jul 2026 27000.00 27160.00 25460.00 26600.00 -1.48%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.